New FDA Genotyping Guidance Opens Door to AmpliChip Rivals | GenomeWeb

NEW YORK, March 11 (GenomeWeb News) - A recently released guidance issued by the US Food and Drug Administration will make it easier for Roche and Affymetrix rivals to win FDA clearance for tests that resemble the AmpliChip drug-metabolism diagnostic, GenomeWeb News has learned.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.